RTI Biologics Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has entered into an agreement with Reimbursement Principles Inc. (RPI), a full service consulting group specializing in medical device reimbursement. The agreement between RTI Biologics and RPI includes the introduction of a toll-free hotline designed to assist hospitals and physician customers with day-to-day reimbursement questions as well as a Web-based service for the submission of requests. “The launch of the hotline with RPI, a pre-eminent expert in the field of reimbursement, demonstrates RTI’s commitment to supporting our customers’ needs and provides a service that is very important given the complex reimbursement guidelines that exist today,” said Roger W. Rose, executive vice president for RTI. The reimbursement hotline, staffed by qualified reimbursement specialists, can provide guidance to questions such as:
Forward Looking StatementThis communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about anticipated financial results, growth rates, new product introductions, future operational improvements and results or regulatory approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting RTI’s Web site at www.rtix.com or the SEC’s Web site at www.sec.gov.